Craig C. Hopkinson, the EVP R&D of $ALKS ($ALKS), sold 61,151 shares of the company on 12-09-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 56.2% of their shares. Following this trade, they now own 47,576 shares of $ALKS stock.
$ALKS Insider Trading Activity
$ALKS insiders have traded $ALKS stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $ALKS stock by insiders over the last 6 months:
- CRAIG C. HOPKINSON (EVP R&D, Chief Medical Officer) has traded it 5 times. They made 0 purchases and 5 sales, selling 154,188 shares.
- CATO T LAURENCIN sold 2,691 shares.
- CHRISTIAN TODD NICHOLS (SVP, Chief Commercial Officer) sold 5,208 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ALKS Hedge Fund Activity
We have seen 172 institutional investors add shares of $ALKS stock to their portfolio, and 192 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HARDMAN JOHNSTON GLOBAL ADVISORS LLC removed 2,674,735 shares (-100.0%) from their portfolio in Q2 2024
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,986,294 shares (+18.0%) to their portfolio in Q3 2024
- WELLINGTON MANAGEMENT GROUP LLP removed 1,696,507 shares (-11.8%) from their portfolio in Q3 2024
- COMMODORE CAPITAL LP added 1,525,000 shares (+110.9%) to their portfolio in Q3 2024
- LOOMIS SAYLES & CO L P added 1,478,422 shares (+365.5%) to their portfolio in Q3 2024
- PACER ADVISORS, INC. removed 1,475,252 shares (-26.2%) from their portfolio in Q3 2024
- WESTFIELD CAPITAL MANAGEMENT CO LP removed 1,316,605 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
